1. Allan JM, Travis LB . Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005; 5: 943–955.
2. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391–2405.
3. International Agency for Research on Cancer. Acute myeloid leukemia (AML) and related precursor neoplasms. In: Swerdlow SH, Ohgaki H (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn, vol. 2008. International Agency for Research on Cancer: Lyon, France, 2008, pp 127–129.
4. Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK et al. New Malignancies Among Cancer Survivors, SEER Cancer Registries, 1973–2000, NIH Publication Number 05-5302. National Cancer Institute: Bethesda, MD, 2006.
5. Ishizawa S, Slovak ML, Popplewell L, Bedell V, Wrede JE, Carter NH et al. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia 2003; 17: 1091–1095.